approved

Приложение 4 на ПЛС от 02.06.2019 г.

Unique identificator:  f09a5d85-659a-4b8f-bb62-2e369d2147cb

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-06-04 09:40:33
  • Created by: georgi_sivchev
  • Updated at: 2019-06-04 09:40:33
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Europe MA EEIG, Обединено Кралство Wyeth Pharmaceuticals, UK 1561.96 312.39 1874.35 4% 10 1571.96 314.39 1886.35 16% 25 1596.96 319.39 1916.35 НСР-5949/01.04.2015. 16.04.2015 16.04.2015 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 1622.03 324.41 1946.44 4% 10 1632.03 326.41 1958.44 16% 25 1657.03 331.41 1988.44 НСР-3992/30.06.2014 15.07.2014 15.07.2014 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 1739.08 347.82 2086.9 4% 10 1749.08 349.82 2098.9 16% 25 1774.08 354.82 2128.9 оставена без разглеждане жалба до Комисия по прозрачност с решение на Комисия по прозрачност КП-241/28.06.2013; КЦРР-2426/22.02.2013 16.10.2013 16.10.2013 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 1852.6 370.52 2223.12 4% 10 1862.6 372.52 2235.12 16% 25 1887.6 377.52 2265.12 промяна в обстоятелствата КЦPP-1521/25.10.2012 КЦ-316/28.11.2008 19.12.2008 19.12.2008 Неактивен 3736
Macrogol, combinations 20060822 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 14.14 2.83 16.97 6% 0.85 14.99 3 17.99 18% 2.55 17.54 3.51 21.05 Промяна на обстоятелства НСР-13979/25.09.2017; НСР-16103/13.07.2018 КЦРР-1094/26.07.2012; НСР-16104/13.07.2018 02.08.2018 02.08.2018 Активен 1310
Macrogol, combinations 20060822 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 10.07 2.01 12.08 6% 0.6 10.67 2.13 12.8 18% 1.81 12.48 2.5 14.98 Промяна на обстоятелства НСР-13979/25.09.2017 КЦРР-1094/26.07.2012 10.08.2012 02.11.2017 Неактивен 1310
Macrogol, combinations 5378/ 13.07.2009 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 10.07 2.01 12.08 6% 0.6 10.67 2.13 12.8 18% 1.81 12.48 2.5 14.98 КЦРР-1094/26.07.2012 10.08.2012 10.08.2012 Неактивен 1310
Macrogol, combinations 5378/13.07.2009 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 12.3 2.46 14.76 8% 0.98 13.28 2.66 15.94 20% 2.46 15.74 3.15 18.89 КЦ-1412/22.02.2010 10.03.2010 10.03.2010 Неактивен 1310
Cyclophosphamide 20020299 Endoxan, Powder for solution for injection, 500, mg, Pack: 1 Екофарм Груп АД, България Екофарм ЕООД, България 20.73 4.15 24.88 6% 1.24 21.97 4.39 26.36 18% 3.73 25.7 5.14 30.84 НСР-13864/14.09.2017 29.09.2017 02.10.2017 Активен 15853
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Екофарм Груп АД, България Екофарм ЕООД, България 41.46 8.29 49.75 4% 1.66 43.12 8.62 51.74 16% 6.63 49.75 9.95 59.7 промяна обстоятелства НСР-13370/28.07.2017; НСР-13712/01.09.2017 КЦРР-2309/20.02.2013; НСР-15268/16.03.2018 08.03.2013 02.04.2018 Заличен 1666
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Екофарм Груп АД, България Екофарм ЕООД, България 41.46 8.29 49.75 4% 1.66 43.12 8.62 51.74 16% 6.63 49.75 9.95 59.7 промяна обстоятелства НСР-13370/28.07.2017; НСР-13712/01.09.2017 КЦРР-2309/20.02.2013 08.03.2013 02.10.2017 Неактивен 1666
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Екофарм Груп АД, България Baxter Oncology GmbH - Germany 41.46 8.29 49.75 4% 1.66 43.12 8.62 51.74 16% 6.63 49.75 9.95 59.7 промяна обстоятелства НСР-13370/28.07.2017 КЦРР-2309/20.02.2013 08.03.2013 02.09.2017 Неактивен 1666
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Baxter Oncolcogy GmbH, Германия Baxter Oncology GmbH - Germany 41.46 8.29 49.75 4% 1.66 43.12 8.62 51.74 16% 6.63 49.75 9.95 59.7 КЦРР-2309/20.02.2013 08.03.2013 08.03.2013 Неактивен 1666
Cyclophosphamide II-1255/ 13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Baxter Oncolcogy GmbH, Германия Baxter Oncology GmbH - Germany 42.19 8.44 50.63 4% 1.69 43.88 8.78 52.66 16% 6.75 50.63 10.13 60.76 КЦ-950/10.06.2009 30.06.2009 30.06.2009 Неактивен 1666
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 500, mg, Pack: 1 Baxter Oncolcogy GmbH, Германия Baxter Oncology GmbH - Germany 3.77 0.75 4.52 7% 0.26 4.03 0.81 4.84 20% 0.75 4.78 0.96 5.74 Цената се вписва в регистъра на пределните цени с решение НСР-2722/06.02.2014 КЦРР-2309/20.02.2013 08.03.2013 08.03.2013 Заличен 1667
Cyclophosphamide II-1256/ 13.12.2007 ENDOXAN, Powder for solution for injection, 500, mg, Pack: 1 Baxter Oncolcogy GmbH, Германия Baxter Oncology GmbH - Germany 4.19 0.84 5.03 7% 0.29 4.48 0.9 5.38 20% 0.84 5.32 1.06 6.38 КЦ-950/10.06.2009 30.06.2009 30.06.2009 Неактивен 1667
Trimetazidine 20110185 Energotrim, Modified release tablet, 35, mg, Pack: 60 Sandoz d.d., Словения Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom 7.76 1.55 9.31 7% 0.54 8.3 1.66 9.96 20% 1.55 9.85 1.97 11.82 НСР-3198/07.04.2014; НСР-9769/14.07.2016 21.04.2014 02.08.2016 Заличен 2682
Trimetazidine 20110185 Energotrim, Modified release tablet, 35, mg, Pack: 60 Sandoz d.d., Словения Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom 7.76 1.55 9.31 7% 0.54 8.3 1.66 9.96 20% 1.55 9.85 1.97 11.82 НСР-3198/07.04.2014 21.04.2014 21.04.2014 Неактивен 2682
Trimetazidine 20110185 Energotrim, Modified release tablet, 35, mg, Pack: 60 Sandoz d.d., Словения Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom 7.94 1.59 9.53 7% 0.56 8.5 1.7 10.2 20% 1.59 10.09 2.02 12.11 КЦРР-1718/28.11.2012 г 01.01.2013 01.01.2013 Неактивен 2682
Hepatitis B, purified antigen 20000247 Engerix B, Suspension for injection, 20 mcg/1.0 ml, -, Pack: 1 pre-filled syringe GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals s.a., Белгия 16.7 3.34 20.04 6% 1 17.7 3.54 21.24 18% 3.01 20.71 4.14 24.85 КЦРР-2557/14.03.2013; НСР-12476/28.04.2017 г.; НСР-16124/13.07.2018; НСР-18291/28.03.2019 12.04.2019 02.05.2019 Активен 1730
Hepatitis B, purified antigen 20000247 Engerix B, Suspension for injection, 20 mcg/1.0 ml, -, Pack: 1 pre-filled syringe GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals s.a., Белгия 16.76 3.35 20.11 6% 1.01 17.77 3.55 21.32 18% 3.02 20.79 4.16 24.95 КЦРР-2557/14.03.2013; НСР-12476/28.04.2017 г.; НСР-16124/13.07.2018 28.07.2018 02.08.2018 Неактивен 1730
Hepatitis B, purified antigen 20000246 Engerix B, Suspension for injection, 10 mcg/0.5 ml, -, Pack: 1 pre-filled syringe GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 11.85 2.37 14.22 6% 0.71 12.56 2.51 15.07 18% 2.13 14.69 2.94 17.63 НСР-8323/26.02.2016; НСР-10750/27.10.2016; НСР-13274/20.07.2017; НСР-17028/19.10.2018 03.11.2018 02.12.2018 Активен 2998
Hepatitis B, purified antigen 20000246 Engerix B, Suspension for injection, 10 mcg/0.5 ml, -, Pack: 1 pre-filled syringe GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 11.93 2.39 14.32 6% 0.72 12.65 2.53 15.18 18% 2.15 14.8 2.96 17.76 НСР-8323/26.02.2016; НСР-10750/27.10.2016; НСР-13274/20.07.2017 04.08.2017 02.09.2017 Неактивен 2998
Hepatitis B, purified antigen 20000247 Engerix B, Suspension for injection, 20 mcg/1.0 ml, -, Pack: 1 pre-filled syringe GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals s.a., Белгия 16.94 3.39 20.33 6% 1.02 17.96 3.59 21.55 18% 3.05 21.01 4.2 25.21 КЦРР-2557/14.03.2013; НСР-12476/28.04.2017 г. 13.05.2017 02.06.2017 Неактивен 1730
Hepatitis B, purified antigen 20000246 Engerix B, Suspension for injection, 10 mcg/0.5 ml, -, Pack: 1 pre-filled syringe GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 12.01 2.4 14.41 6% 0.72 12.73 2.55 15.28 18% 2.16 14.89 2.98 17.87 НСР-8323/26.02.2016; НСР-10750/27.10.2016 02.12.2016 02.12.2016 Неактивен 2998
Showing 4126 to 4151 of 14923 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте